Efficacy and safety of anagrelide in childhood essential thrombocythemia

Pediatr Int. 2017 Sep;59(9):1017-1018. doi: 10.1111/ped.13330. Epub 2017 Jul 14.

Authors

Ayako Kanai¹, Hirokazu Morokawa², Kazuyuki Matsuda³, Ei Shimazaki¹, Yozo Nakazawa²

Affiliations

¹ Department of Pediatrics, National Hospital Organization Shinshu Ueda Medical Center, Ueda, Japan.
² Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
³ Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.

PMID: 28707720
DOI: 10.1111/ped.13330

No abstract available

Keywords: anagrelide; child; essential thrombocythemia.

Publication types

Case Reports

MeSH terms

Child
Female
Humans
Platelet Aggregation Inhibitors / therapeutic use*
Quinazolines / therapeutic use*
Thrombocythemia, Essential / drug therapy*

Substances

Platelet Aggregation Inhibitors
Quinazolines
anagrelide